Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Manufacturing of Pharmaceutical Products	619.51M	537.49M	394.92M	448.61M
Manufacturing of Pharmaceutical Products Growth	15.26%	36.10%	-11.97%	-
Total	619.51M	537.49M	394.92M	448.61M
Total Growth	15.26%	36.10%	-11.97%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	619.51M	537.49M	394.92M	448.61M
India Growth	15.26%	36.10%	-11.97%	-
Total	619.51M	537.49M	394.92M	448.61M
Total Growth	15.26%	36.10%	-11.97%	-

Source: S&P Global Market Intelligence.